Responses
Clinical/translational cancer immunotherapy
Original research
Biomarkers of pembrolizumab efficacy in advanced anal squamous cell carcinoma: analysis of a phase II clinical trial and a cohort of long-term responders
Compose a Response to This Article
Other responses
No responses have been published for this article.
